Maven Clinic Expands Fertility Platform With Earlier Diagnostics and Oura Integration to Cut Employer Spend

New updates have been reported about Maven Clinic.

Maven Clinic is broadening its Fertility & Family Building offering with earlier diagnostic lab testing, new condition-specific care pathways, and integrated ovulation prediction data from Oura, aiming to move members into appropriate care faster while improving cost efficiency for employers. The program targets a key cost driver in benefits—rising fertility spending—by using lab, wearable, and clinical data to reduce delayed diagnoses, unnecessary interventions, and high-cost procedures.

Under the expansion, Maven will embed hormone and genetic carrier testing earlier in the care journey, returning results directly in its platform to support faster referrals and more informed clinical decisions. Maven is also rolling out structured care programs for PCOS, endometriosis, and oncofertility, and is the first to integrate FDA-listed ovulation prediction insights from Oura into a fertility navigation experience, all orchestrated by its AI layer, Maven Intelligence. These changes build on outcomes already reported—30% of members conceiving without assisted reproductive technology and average savings of $9,600 per birth across fertility and maternity—positioning Maven to deepen its value proposition to more than 2,300 employer and health plan clients and strengthen its competitive moat in virtual women’s and family health.